Clinical Trials

Ongoing Trials

Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALS

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) (FORTITUDE-ALS)

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS (REFALS)

Genomic Translation for Amyotrophic Lateral Sclerosis Care (GTAC)

AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) (CENTAUR)

An up-to-date listing of our studies can be found here

Completed trials

Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year (VITALITY-ALS)
This is an international Phase 3 study of tirasemtiv

Clinical Trial of Ezogabine (Retigabine) in ALS Subjects
• ALS Association press release

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (Mexiletine-2)

For questions on clinical trials at the University of Michigan, please email Jayna Duell at jkballar@med.umich.edu